Joseph McKendrick
Eastern Health(AU)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Colorectal Cancer Surgical Treatments, Colorectal and Anal Carcinomas, Cancer Treatment and Pharmacology, Gastric Cancer Management and Outcomes
Most-Cited Works
- → Capecitabine as Adjuvant Treatment for Stage III Colon Cancer(2005)1,245 cited
- → Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04(2012)913 cited
- → Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer(2019)670 cited
- → Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients(2006)298 cited
- → Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial(2013)237 cited
- → The Granzyme B Inhibitor, PI-9, Is Present in Endothelial and Mesothelial Cells, Suggesting That It Protects Bystander Cells during Immune Responses(2001)85 cited
- → The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04)(2016)62 cited
- → Velour trial biomarkers update: Impact of RAS, BRAF, and sidedness on aflibercept activity.(2017)56 cited
- → Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy(2015)47 cited
- → Capecitabine: effective oral fluoropyrimidine chemotherapy(2005)29 cited